Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Stem Cell Reports|April 15, 2022
Engineered three-dimensional cardiac tissues maturing in a rotating wall vessel bioreactor remodel diseased hearts in rats with myocardial infarctionTaro Nakazato, Takuji Kawamura, Toshimasa Uemura, et al.
Scientific Reports|January 15, 2016
Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in MiceAi Kawamura, Shigeru Miyagawa, Satsuki Fukushima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 9, 2013
In vivo differentiation of induced pluripotent stem cell-derived cardiomyocytesTao Yu, Shigeru Miyagawa, Kenji Miki, et al.
Scientific Reports|February 15, 2019
Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical applicationEmiko Ito, Shigeru Miyagawa, Maki Takeda, et al.
Tissue Engineering. Part A|May 13, 2017
Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac TissueHiroko Iseoka, Shigeru Miyagawa, Satsuki Fukushima, et al.
Stem Cells Translational Medicine|September 18, 2015
Structural Changes in N-Glycans on Induced Pluripotent Stem Cells Differentiating Toward CardiomyocytesTakuji Kawamura, Shigeru Miyagawa, Satsuki Fukushima, et al.
The Annals of Thoracic Surgery|August 2, 2017
Histone Modification Is Correlated With Reverse Left Ventricular Remodeling in Nonischemic Dilated CardiomyopathyEmiko Ito, Shigeru Miyagawa, Satsuki Fukushima, et al.
Circulation|September 14, 2013
Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heartMasashi Kawamura, Shigeru Miyagawa, Satsuki Fukushima, et al.
Tissue Engineering. Part C, Methods|October 3, 2017
Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem CellsMaki Takeda, Shigeru Miyagawa, Satsuki Fukushima, et al.
Scientific Reports|March 16, 2019
CXCL4/PF4 is a predictive biomarker of cardiac differentiation potential of human induced pluripotent stem cellsFumiya Ohashi, Shigeru Miyagawa, Satoshi Yasuda, et al.
Pageof 5